Pan et al. examine the role of Des-γ-carboxy prothrombin as a prognostic biomarker for hepatocellular carcinoma recurrence risk post-surgery. Findings expand the clinical utility of an existing biomarker beyond diagnostics to include recurrence monitoring and screening.
- Xinting Pan
- Yang Zhou
- Xiaolong Liu
